Christopher Freese, M.D.
NPI 1689084261 · Radiation Oncology Physician · Cincinnati, OH
Enrolled with Medicare as Practitioner - Radiation Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1689084261
- Entity type
- Individual
- Primary specialty
- Radiation Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 35.138179 (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
12 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,667 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Ct Guidance for Insertion of Radiation Therapy Fields77014 | 447 | $42 |
| Ct Guidance for Insertion of Radiation Therapy Fields77014 | 265 | $42 |
| Calculation of Radiation Therapy Dose77300 | 131 | $31 |
| Radiation Treatment Management, 5 Treatment Sessions77427 | 104 | $181 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 98 | $62 |
| Design and Construction of Complex Radiation Treatment Device77334 | 90 | $55 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 114 | 42 |
| Oxycodone Hcl | 31 | 16 |
| Oxybutynin Chloridebrand: Oxybutynin Chloride Er | 25 | 13 |
| Venlafaxine Hclbrand: Venlafaxine Hcl Er | 13 | — |
| Methylprednisolone | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-05-05
- Last updated
- 2020-10-21
- Certified
- 2020-10-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.